Similar Papers

Paper Title
Journal
Date
Author
132-OR: Effects of Dapagliflozin, an SGLT2 Inhibitor, on Hepatic Steatosis and Fibrosis Evaluated by Transient Elastography in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Yoshimasa Aso ... Toshie Iijima
Diabetes | VOL. 68
Yoshimasa Aso, et. al.Yoshimasa Aso ... Toshie Iijima
01 Jun 2019
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
Masanori Shimizu ... Yoshimasa Aso
Diabetes, Obesity and Metabolism | VOL. 21
Masanori Shimizu, et. al.Masanori Shimizu ... Yoshimasa Aso
02 Oct 2018
Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease.
Yoshimasa Aso ... Isao Usui
International Journal of Clinical Practice | VOL. 73
Yoshimasa Aso, et. al.Yoshimasa Aso ... Isao Usui
01 Apr 2019
1229-P: Dapagliflozin Improves Liver Dysfunction in Parallel with a Decrease in Serum Soluble DPP-4/CD26 Level in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
Kanako Kato ... Isao Usui
Diabetes | VOL. 68
Kanako Kato, et. al.Kanako Kato ... Isao Usui
01 Jun 2019
View more papers

More From: Journal of Investigative Medicine

Paper Title
Journal
Date
Author
Abstracts
-
Journal of Investigative Medicine | VOL. 73
--
13 Dec 2024
2024 International Conference of Psychiatry and Neurorestoratology - Selected Abstracts on Medicine and Medical Care
-
Journal of Investigative Medicine | VOL. 72
--
21 Nov 2024
Introduction of 2024 International Conference on Advances in Biological Science and Technology, September 28-30, 2024, Online Video Conference
-
Journal of Investigative Medicine | VOL. -
--
18 Oct 2024
2024 Midwest Clinical & Translational Research Meeting Abstract Supplement
-
Journal of Investigative Medicine | VOL. 72
--
01 Oct 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.